RNASE4 and inflammatory bowel disease: The exacerbation of colitis observed in Rnase4-deficient mice, as well as the association between Rnase4 and gut microbiota dysbiosis, imply possible clinical potential of RNASE4 in IBD management, including Ulcerative colitis (UC) and Crohn’s disease (CD).